Suppr超能文献

间歇性腹膜透析与生存结局:一项倾向匹配队列研究。

Incremental peritoneal dialysis and survival outcomes: a propensity-matched cohort study.

作者信息

Liu Ruihua, Ye Hongjian, Peng Yuan, Yi Chunyan, Lin Jianxiong, Wu Haishan, Diao Xiangwen, Mao Haiping, Huang Fengxian, Yang Xiao

机构信息

Department of Nephrology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, Guangdong, China.

NHC Key Laboratory of Clinical Nephrology (Sun Yat-Sen University) and Guangdong Provincial Key Laboratory of Nephrology, Guangzhou, 510080, China.

出版信息

J Nephrol. 2023 Sep;36(7):1907-1919. doi: 10.1007/s40620-023-01735-4. Epub 2023 Aug 21.

Abstract

BACKGROUND

The advantages of an incremental dialysis start are not fully clear. We aimed to evaluate the association of incremental initiation of peritoneal dialysis with mortality.

METHODS

Incident peritoneal dialysis patients with a catheter placed at our hospital between 2008 and 2017 were included. All patients were followed up until December 31, 2019. Patients were categorized into different groups according to the initial daily dialysis exchanges, and were matched at a ratio of 1:2 with propensity score matching. Multiple variables including age, sex, residual kidney function, urine volume, hemoglobin, serum albumin and other important variables were included for the matching. Primary outcomes were all-cause and cardiovascular mortality.

RESULTS

A total of 1315 patients with a mean age of 45.9 years were enrolled. The mean glomerular filtration rate was 4.32 ml/min/1.73 m at start of dialysis. Two hundred eighty-five patients in the incremental group and 502 in the full dose group were matched for age, sex, residual kidney function, urine volume, hemoglobin, serum albumin and other important variables. Patient survival and cardiovascular event-free survival were similar between the two groups. However, during the first 6 years of peritoneal dialysis, patients in the incremental group had better survival (P = 0.011) and cardiovascular event-free survival (P = 0.044) than the full dose group, while such advantages disappeared when dialysis vintage became longer. Further analysis showed that the incremental group (vs full dose dialysis) had a 39% lower risk (95% CI 0.42-0.90, P = 0.012) of all-cause mortality and a 41% decreased risk (95% CI 0.35-0.99, P = 0.047) of cardiovascular mortality during the first 6 years of dialysis. Additionally, the cumulative hazard for anuria was significantly lower in the incremental group versus the full dose group (P = 0.006).

CONCLUSIONS

Our study shows a time-related survival advantage for incremental peritoneal dialysis patients, suggesting that an incremental regimen for starting peritoneal dialysis is feasible and is not associated with worse outcomes. Graphical Abstract presenting schematically the measurements of the solvation response function by processing the relevant streak camera images and the time-correlated photon counting (TCSPC) data and appropriately combining them together.

摘要

背景

逐步开始透析的优势尚不完全明确。我们旨在评估腹膜透析逐步起始与死亡率之间的关联。

方法

纳入2008年至2017年期间在我院置入导管的新发腹膜透析患者。所有患者随访至2019年12月31日。根据初始每日透析交换量将患者分为不同组,并采用倾向得分匹配以1:2的比例进行匹配。匹配纳入年龄、性别、残余肾功能、尿量、血红蛋白、血清白蛋白等多个变量。主要结局为全因死亡率和心血管死亡率。

结果

共纳入1315例患者,平均年龄45.9岁。透析开始时平均肾小球滤过率为4.32 ml/min/1.73 m²。逐步组的285例患者和全剂量组的502例患者在年龄、性别、残余肾功能、尿量、血红蛋白、血清白蛋白等重要变量方面进行了匹配。两组患者的生存情况和无心血管事件生存率相似。然而,在腹膜透析的前6年,逐步组患者的生存率(P = 0.011)和无心血管事件生存率(P = 0.044)优于全剂量组,但随着透析龄延长,这种优势消失。进一步分析显示,在透析的前6年,逐步组(与全剂量透析相比)全因死亡率风险降低39%(95%CI 0.42 - 0.90,P = 0.012),心血管死亡率风险降低41%(95%CI 0.35 - 0.99,P = 0.047)。此外,逐步组无尿的累积风险显著低于全剂量组(P = 0.006)。

结论

我们的研究显示了腹膜透析逐步起始患者与时间相关的生存优势,表明腹膜透析逐步起始方案是可行的,且与较差结局无关。示意图展示了通过处理相关条纹相机图像和时间相关单光子计数(TCSPC)数据并将它们适当组合在一起对溶剂化响应函数进行测量的过程。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验